DERMO ADJUVANTS SPECIFIFIC TREATMENT FOR DIABETIC FEET AKILDIA DERMO ADJUVANTS SPECIFIFIC TREATMENT...

AKILDIA DERMO ADJUVANTS DERMO ADJUVANTS

SPECIFIFIC TREATMENT SPECIFIFIC TREATMENT

FOR DIABETIC FEETFOR DIABETIC FEET

®

DOC SSL 14 12 05 V1

LABORATOIRES ASEPTA - MONACOLABORATOIRES ASEPTA - MONACO

DIABETESDIABETES

A few figuresA few figures

What are the consequences for the feet?What are the consequences for the feet?

Preventive foot care for diabeticsPreventive foot care for diabetics

Advice to give to diabetics on foot careAdvice to give to diabetics on foot care

®® AKILDIA AKILDIA TREATMENT AND PREVENTIVE CARE FOR THE FEET TREATMENT AND PREVENTIVE CARE FOR THE FEET

OF DIABETICSOF DIABETICS

A few figuresA few figures

DIABETESDIABETES

®® AKILDIA AKILDIA TREATMENT AND PREVENTIVE CARE FOR THE FEET TREATMENT AND PREVENTIVE CARE FOR THE FEET OF DIABETICSOF DIABETICS

DERMO ADJUVANTSDERMO ADJUVANTS

In 2003:In 2003: 189 million diabetics in the world 189 million diabetics in the world

- Type II diabetes: around 90 % of al cases- Type II diabetes: around 90 % of al cases

20 millions en Europe. 1.7million in France.1.7million in France. 4.1 million in Germany.4.1 million in Germany.

2.5 million recorded in Poland (9 % of the population)2.5 million recorded in Poland (9 % of the population) 14 millions in the USA (20 millions in 2010).

In 2025: In 2025: 333 millions throughout the world333 millions throughout the world

DIABETESDIABETES


Évolution de la population diabétique dans le mondeÉvolution de la population diabétique dans le monde

Around 333 million in 2025 = 6.3%Around 333 million in 2025 = 6.3%

DEVELOPMENT OF DIABETES IN THE WORLDDEVELOPMENT OF DIABETES IN THE WORLD


Around 177 million In 2003 = 5.1%Around 177 million In 2003 = 5.1%

What are the consequences What are the consequences

for the feet?for the feet?

DIABETESDIABETES



CONSEQUENCES FOR THE FEET CONSEQUENCES FOR THE FEET

NERVENERVE AND AND ARTERY ARTERY PROBLEMS IN THE LOWER LIMBSPROBLEMS IN THE LOWER LIMBSCAUSE CAUSE TROPHIC SKIN PROBLEMS IN THE FEET.TROPHIC SKIN PROBLEMS IN THE FEET.

THESE PATHOLOGIES THESE PATHOLOGIES (neurological and vascular)(neurological and vascular) ARE OFTEN ARE OFTENLINKED TO AND ARE LINKED TO AND ARE WORSENED BY A RISK OF INFECTION.WORSENED BY A RISK OF INFECTION.

THE FEET OF DIABETICS = THE FEET OF DIABETICS = A FRAGILE FOOTA FRAGILE FOOT

®® AKILDIA AKILDIA CARE AND PREVENTION FOR THE FEET OF CARE AND PREVENTION FOR THE FEET OF

DIABETICSDIABETICS

FOOT INFECTION:FOOT INFECTION: 40 times higher in diabetics. 40 times higher in diabetics. It can be caused by a trauma or following trophic problems and fissural It can be caused by a trauma or following trophic problems and fissural

hyperkeratosis.hyperkeratosis.

RISK OF GANGRENE:RISK OF GANGRENE: 17 times higher in diabetics.17 times higher in diabetics.

50 % 50 % of lower limb amputations are performed on diabetics. of lower limb amputations are performed on diabetics. 5 to 15 %5 to 15 % of diabetics undergo the amputation of a toe, a foot or a leg. of diabetics undergo the amputation of a toe, a foot or a leg. 25 %25 % of hospitalisations of diabetics are due to a foot problem. of hospitalisations of diabetics are due to a foot problem.

““NEUROLOGICAL” FOOTNEUROLOGICAL” FOOT

CONSEQUENCE OF NEUROPATHIA - CHARACTERISED BY:CONSEQUENCE OF NEUROPATHIA - CHARACTERISED BY:

- Total or partial loss of sensation- Total or partial loss of sensation

- Increased blood flow with opening of arterial and venal shunts - Increased blood flow with opening of arterial and venal shunts - osteoporosis (fractures)- osteoporosis (fractures)- malformation of the foot- malformation of the foot- reduction in perspiration: intense dehydration- reduction in perspiration: intense dehydration

Consequences for the skinConsequences for the skin: : very dry, hard skin with zones of hyperkeratosis. very dry, hard skin with zones of hyperkeratosis. Protective function disturbed: opening door to infectionsProtective function disturbed: opening door to infections

Major riskMajor risk: :

Wound breaking through the sole of the footWound breaking through the sole of the foot

Very high risk of over-infection and gangrene.Very high risk of over-infection and gangrene.

Hooked toesHooked toes

pes cavus pes cavus


““VASCULAR” FOOTVASCULAR” FOOTCONSEQUENCE OF MACRO-ANGIOPATHIA OF THE LOWER LIMBS CONSEQUENCE OF MACRO-ANGIOPATHIA OF THE LOWER LIMBS DIABETIC ARTERITIS IS CHARACTERISÉD BY:DIABETIC ARTERITIS IS CHARACTERISÉD BY:

- Nocturnal pains- Nocturnal pains - Intermittent claudication - Intermittent claudication - Pale, cold foot - Pale, cold foot - Weak pulse - Weak pulse - Absence of hair - Absence of hair - Hyperonychia - Hyperonychia - Ischemic foot - Ischemic foot

Consequences for the skinConsequences for the skin: : Thin, fragile skin, atrophied skin tissue, skin healing problems due to a blood flow Thin, fragile skin, atrophied skin tissue, skin healing problems due to a blood flow deficiency in the small blood vesselsdeficiency in the small blood vessels

Major riskMajor risk: : risk of ischemia - necrosis.risk of ischemia - necrosis.

Very high risk of over-infection and gangrene.Very high risk of over-infection and gangrene.


Preventive care for the feet of Preventive care for the feet of

diabeticsdiabetics



GENERAL ADVICE FOR FOOT PROBLME RISKS:GENERAL ADVICE FOR FOOT PROBLME RISKS:

CONSULT DOCTOR IMMEDIATELYCONSULT DOCTOR IMMEDIATELY

(strict control of the diabetes, treatment of superficial infections , (strict control of the diabetes, treatment of superficial infections , anti-tetanus prophylaxis, prevention of ischemia…..)anti-tetanus prophylaxis, prevention of ischemia…..)


PREVENTION:PREVENTION:

- Checking the foot through consultation of a range of multidisciplinary - Checking the foot through consultation of a range of multidisciplinary specialists and education suited to the patient and their family.specialists and education suited to the patient and their family.- Screening for neuropathia and arteriopathia - Screening for neuropathia and arteriopathia - Monthly visits to a foot care specialist (ablation of hyperkeratoses, cutting of - Monthly visits to a foot care specialist (ablation of hyperkeratoses, cutting of nails, orthoses to compensate for the foot statics)nails, orthoses to compensate for the foot statics)

- Daily foot examination- Daily foot examination

- Regular and vigorous foot hygiene regime- Regular and vigorous foot hygiene regime

- Daily use of a foot product to:- Daily use of a foot product to: hydrate the skinhydrate the skin prevent the appearance of hyperkeratosisprevent the appearance of hyperkeratosis retain the protective role of the skinretain the protective role of the skin


AKILDIA CREAM

DERMO ADJUVANTS DERMO ADJUVANTS SPECIFIC FOOT CARESPECIFIC FOOT CARE

FOR DIABETICSFOR DIABETICS

SPECIFIC FOOT HYGIENESPECIFIC FOOT HYGIENEFOR DIABETICSFOR DIABETICS

SPECIFIC FOOT CARESPECIFIC FOOT CAREFOR DIABETICSFOR DIABETICS

®


®® AKILDIA AKILDIA TREATMENT AND PREVENTIVE CARE FOR THE FEET TREATMENT AND PREVENTIVE CARE FOR THE FEET

OF DIABETICSOF DIABETICS

AKILDIA

SPECIFIC FOOT CARESPECIFIC FOOT CAREFOR DIABETICSFOR DIABETICS

®


PRODUCT ADVANTAGESPRODUCT ADVANTAGES

- Keeps foot hydrated- Keeps foot hydrated- Restores the barrier function- Restores the barrier function- Helps the foot keep its softness - Helps the foot keep its softness for protection for protection - Prevention of hyperkeratosis- Prevention of hyperkeratosis- Helps the skin tissue healing process- Helps the skin tissue healing process

®

PRESCRIPTION AND USE ADVICEPRESCRIPTION AND USE ADVICE

Skin dryness and foot hyperkeratosis for diabeticsSkin dryness and foot hyperkeratosis for diabetics

®® AKILDIA AKILDIA TREATMENT AND PREVENTIVE CARE FOR THE TREATMENT AND PREVENTIVE CARE FOR THE

FEET OF DIABETICSFEET OF DIABETICS Formula designed to meet the

needs of diabetics

From pluridisciplinary collaboration between diabetology specialists,

chiropodists and pharmacists

Recognised by the French Diabetics Association

Used and recommended in hospitals

®®AKILDIA CREAMAKILDIA CREAM

FOOT PROTECTION CREAMFOOT PROTECTION CREAM

ACTIVE SUBSTANCES FOR TOTAL LOCAL TREATMENT OF THE ACTIVE SUBSTANCES FOR TOTAL LOCAL TREATMENT OF THE

FEET OF DIABETICSFEET OF DIABETICS

MOISTURISE AND RESTORE THE HYDRO-LIPIDIC BARRIER MOISTURISE AND RESTORE THE HYDRO-LIPIDIC BARRIER Essential fatty acids and shea butter in a non-occlusive H/E emulsion Essential fatty acids and shea butter in a non-occlusive H/E emulsion

HELP HEALING PROCESS AND ACT ON THE MICRO-CIRCULATION HELP HEALING PROCESS AND ACT ON THE MICRO-CIRCULATION Centella Asiatica Centella Asiatica

CALM AND MAINTAIN THE PHYSIOLOGICAL BALANCE OF THE SKINCALM AND MAINTAIN THE PHYSIOLOGICAL BALANCE OF THE SKIN Palmitoyl caseinic lipo-amino acidPalmitoyl caseinic lipo-amino acid

HELP HELP PREVENT HYPERKERATOSIS PREVENT HYPERKERATOSIS vitamin A palmitate vitamin A palmitate


CREME CREME ®®AKILDIAAKILDIA

FOOT PROTECTION CREAMFOOT PROTECTION CREAM

PROVEN EFFECTIVENESS IN SEVERAL CLINICAL CLINICAL STUDIESPROVEN EFFECTIVENESS IN SEVERAL CLINICAL CLINICAL STUDIES

1111

HEALING EFFECT ON FISSURAL HYPERKERATOSES ON THE SOLE OF THE FOOTHEALING EFFECT ON FISSURAL HYPERKERATOSES ON THE SOLE OF THE FOOT

DOUBLE BLIND CLINICAL STUDY USING A PLACEBO ON THE EFFECTIVENESS OF AKILDIA CREAM ON DOUBLE BLIND CLINICAL STUDY USING A PLACEBO ON THE EFFECTIVENESS OF AKILDIA CREAM ON THE REDUCTION OF HYPERKERATOSIS AND SKIN DRYNESSTHE REDUCTION OF HYPERKERATOSIS AND SKIN DRYNESS

CLINICAL STUDY ON THE EFFECTIVENESS OF THE AKILDIA CREAM ON THE REDUCTION OF CLINICAL STUDY ON THE EFFECTIVENESS OF THE AKILDIA CREAM ON THE REDUCTION OF HYPERKERATOSIS AND SKIN DRYNESSHYPERKERATOSIS AND SKIN DRYNESS

2222

3333

In hospitals – Under dermatological control – In sports medicine – By chiropodistsIn hospitals – Under dermatological control – In sports medicine – By chiropodists


3333 STUDY ON THE USE OF AKILDIA IN SPORTSTUDY ON THE USE OF AKILDIA IN SPORT

1111

CLINICAL STUDY ON THE EFFECTIVENESS OF AKILDIA CREAM ON CLINICAL STUDY ON THE EFFECTIVENESS OF AKILDIA CREAM ON

THE REDUCTION OF HYPERKERATOSIS AND SKIN DRYNESSTHE REDUCTION OF HYPERKERATOSIS AND SKIN DRYNESS


HOTEL DIEU at LE CREUSOT (France) HOTEL DIEU at LE CREUSOT (France) DIABETOLOGY DEPARTMENT of DR. S.CLAVELDIABETOLOGY DEPARTMENT of DR. S.CLAVEL

STUDY CONDITIONS :STUDY CONDITIONS :

• 50 diabetic patients50 diabetic patients- 100% neuropathia of the lower limbs- 100% neuropathia of the lower limbs- 64% macro-angiopathia- 64% macro-angiopathia -60% serious foot problems (wounds breaking through the sole of the foot, -60% serious foot problems (wounds breaking through the sole of the foot,

necrosis of the toes, feet or legs, wounds of bedsores) necrosis of the toes, feet or legs, wounds of bedsores)- 40% minor trophic skin problems- 40% minor trophic skin problems

• 2 month treatment, 1 application per day.2 month treatment, 1 application per day.


RESULTS:RESULTS:

ASSESSMENT OF THE EFFECTIVENESS OF THE AKILDIA® CREAM ON THE REDUCTION OF ASSESSMENT OF THE EFFECTIVENESS OF THE AKILDIA® CREAM ON THE REDUCTION OF HYPERKERATOSIS AND SKIN DRYNESSHYPERKERATOSIS AND SKIN DRYNESS

• VERY HIGH LEVEL OF SKIN TOLERANCE WITH AKILDIA® CREAM ( 96 % of subjects)VERY HIGH LEVEL OF SKIN TOLERANCE WITH AKILDIA® CREAM ( 96 % of subjects)

• GOOD EFFECTIVENSS ON THE REDUCTION OF HYPERKERATOSIS, SKIN DRYNESS. GOOD EFFECTIVENSS ON THE REDUCTION OF HYPERKERATOSIS, SKIN DRYNESS.

• IMPROVEMENT IN SOFTNESS AND ELASTICITY OF SKIN. IMPROVEMENT IN SOFTNESS AND ELASTICITY OF SKIN.

55.3% 31.9%

12.8%0%

10%

20%

30%

40%

50%

60%

Excellent effectiveness of Akildia® cream in 55.3% of subjectsGood effectiveness of Akildia® cream in 31.9% of subjectsAverage effectiveness of Akildia® cream in 12.8 % of subjects

2222

DOUBLE BLIND CLINICAL STUDY USING PLACEBO ON THE DOUBLE BLIND CLINICAL STUDY USING PLACEBO ON THE

EFFECTIVENSS OF AKILDIA CREAM ON THEEFFECTIVENSS OF AKILDIA CREAM ON THE

REDUCTION OF HYPERKERATOSISREDUCTION OF HYPERKERATOSIS

AND SKIN DRYNESS AND SKIN DRYNESS


SWEDEN SWEDEN DIABETOLOGY DEPARTMENT DR. SKARBERGDIABETOLOGY DEPARTMENT DR. SKARBERG


• 24 diabetic patients :24 diabetic patients :

- 70.8 %: neuropathia of lower limbs- 70.8 %: neuropathia of lower limbs

- 50 %: arteriopathia- 50 %: arteriopathia

Condition of skin before treatment:Condition of skin before treatment:

- 91.7 %: skin dryness- 91.7 %: skin dryness

- 75 %: hyperkeratosis- 75 %: hyperkeratosis

• 3-month treatment, 2 applications per day.3-month treatment, 2 applications per day.

Right foot: AKILDIA® creamRight foot: AKILDIA® cream

Left foot: placeboLeft foot: placebo


RESULTS :RESULTS :

ASSESSMENT OF THE EFFECTIVENESS OF THE AKILDIA® ASSESSMENT OF THE EFFECTIVENESS OF THE AKILDIA® CREAM ON THE REDUCTION OF HYPERKERATOSIS AND CREAM ON THE REDUCTION OF HYPERKERATOSIS AND SKIN DRYNESSSKIN DRYNESS

• GOOD EFFECTIVESS OF THE AKILDIA CREAM ON THE REDUCTION OF HYPERKERATOSIS AND SKIN DRYNESS. GOOD EFFECTIVESS OF THE AKILDIA CREAM ON THE REDUCTION OF HYPERKERATOSIS AND SKIN DRYNESS.

• SIGNIFICANT DIFFERENCE WITH THE PLACEBO (which is nonetheless not without activity because it is made of the SIGNIFICANT DIFFERENCE WITH THE PLACEBO (which is nonetheless not without activity because it is made of the

excipient of AKILDIA cream, which has a moisturising properties). excipient of AKILDIA cream, which has a moisturising properties).

% subjects

REDUCTION OF SKIN DRYNESSREDUCTION OF SKIN DRYNESS• Good for 86.4% of subjects treated with AKILDIA Good for 86.4% of subjects treated with AKILDIA

• Good for 27.3 % of subjects treated with placeboGood for 27.3 % of subjects treated with placebo

IMPROVEMENT IN HYPERKERATOSIS IMPROVEMENT IN HYPERKERATOSIS • Good for 88.9% of subjects treated with AKILDIA Good for 88.9% of subjects treated with AKILDIA

• Good for 33.3 % of subjects treated with placeboGood for 33.3 % of subjects treated with placebo

86.4%

27.3%0%

20%

40%

60%

80%

100%

88.9%33.3%

0%

20%

40%

60%

80%

100%


RESULTS :RESULTS :

ASSESSEMENT OF THE EFFECTIVENSS OF AKILDIA® CREAM ON THE IMPRROVEMENT ASSESSEMENT OF THE EFFECTIVENSS OF AKILDIA® CREAM ON THE IMPRROVEMENT

OF SKIN SENSITIVITY (OF SKIN SENSITIVITY (filament method)filament method)

• IMPROVEMENT OF THE SENSE OF TOUCH OF THE FOOT TREATED WITH AKILDIA CREAMIMPROVEMENT OF THE SENSE OF TOUCH OF THE FOOT TREATED WITH AKILDIA CREAM

• SIGNIFICANT DIFFERENCE WITH THE PLACEBOSIGNIFICANT DIFFERENCE WITH THE PLACEBO

% subjects

IMPROVEMENT IN SENSE OF TOUCHIMPROVEMENT IN SENSE OF TOUCH

70.6%

17.6%0%

20%

40%

60%

80%

Improvement in skin sensitivity for 70.6% of subjects treated withAkildia® creamImprovement in skin sensitivity for 17.6% of subjects treated with theplacebo

% subjects


RESULTS :RESULTS :

GENERAL ASSESSMENT OF THE EFFECTIVENESS OF AKILDIA® CREAM FOR TREATEMENT GENERAL ASSESSMENT OF THE EFFECTIVENESS OF AKILDIA® CREAM FOR TREATEMENT OF THE FEET OF DIABETICSOF THE FEET OF DIABETICS

• GOOD EFFECTIVESS OF THE AKILDIA CREAM FOR TREATMENT OF FEET OF DIABETICSGOOD EFFECTIVESS OF THE AKILDIA CREAM FOR TREATMENT OF FEET OF DIABETICS

• SIGNIFICANT DIFFERENCE WITH THE PLACEBO (which is nonetheless not without activity because it is SIGNIFICANT DIFFERENCE WITH THE PLACEBO (which is nonetheless not without activity because it is made of the excipient of AKILDIA cream, which has also has moisturising properties). made of the excipient of AKILDIA cream, which has also has moisturising properties).

66.7%

16.7% 16.6%0%

20%

40%

60%

Good effectiveness of the Akildia® cream for 66.7% of subjectsGood effectivess of the placebo for 16.7% of subjectsIdentical effectivess of the Akildia® cream and the placebo in 16.6 % of subjects

3333

STUDY ON THE HEALING EFFECTOF AKILDIA CREAMSTUDY ON THE HEALING EFFECTOF AKILDIA CREAM

ON FISSULAR HYPERKERATOSES ON THE SOLES OF FEET ON FISSULAR HYPERKERATOSES ON THE SOLES OF FEET


TEST PERFORMED UNDER DERMATOLOGICAL CONTROL TEST PERFORMED UNDER DERMATOLOGICAL CONTROL


• 10 patients with fissural hyperkeratosis10 patients with fissural hyperkeratosis

• Two-week treatment. Two-week treatment.

• 2 applications per day. 2 applications per day.

• 1 foot treated, 1 foot as control.1 foot treated, 1 foot as control.

VARIATIONVARIATION IN NUMBER OF FISSURESIN NUMBER OF FISSURES ON THE FOOT TREATEDON THE FOOT TREATEDCOMPARED WITH THE NON-TREATED FOOTCOMPARED WITH THE NON-TREATED FOOT

• Significant reduction in the number of fissures on the foot treated. (-1.8 )Significant reduction in the number of fissures on the foot treated. (-1.8 )

• Increase in the number of fissures on the foot treated. (+0.6 ) Increase in the number of fissures on the foot treated. (+0.6 )

Score*Score* : presence of fissures 0 = zero / 1 = slight / 2 = average/ 3 = significant/ 4 = very significant : presence of fissures 0 = zero / 1 = slight / 2 = average/ 3 = significant/ 4 = very significant/ / 5 = severe5 = severe

BEFORE TREATMENT BEFORE TREATMENT AFTER TWO WEEKS OF TREATMENTAFTER TWO WEEKS OF TREATMENT


RESULTS:RESULTS: HEALING EFFECT OF AKILDIA® CREAM ON FISSULAR HYPERKERATOSIS ON THE SOLES HEALING EFFECT OF AKILDIA® CREAM ON FISSULAR HYPERKERATOSIS ON THE SOLES OF THE FEETOF THE FEET

0

1

2

3

4

5

DO FOOTTREATED

DO FOOT NOTTREATED

Clinical score *

2.75.1

0

1

2

3

4

5

D14 FOOTTREATED

D14 FOOT NOTTREATED

Clinical score *

-1.8 +0.6

RESULTS:RESULTS: HEALING EFFECT OF AKILDIA® CREAM ON FISSULAR HYPERKERATOSISHEALING EFFECT OF AKILDIA® CREAM ON FISSULAR HYPERKERATOSIS ON THE SOLES OF THE FEETON THE SOLES OF THE FEET

®® AKILDIA AKILDIA TREATMENT AND PREVENTATIVE CARE FOR THE TREATMENT AND PREVENTATIVE CARE FOR THE FEET OF DIABETICSFEET OF DIABETICS

VARIATION IN NUMBER OF HYPERKERATOSIS ON THE FOOT TREATEDVARIATION IN NUMBER OF HYPERKERATOSIS ON THE FOOT TREATEDCOMPARED WITH THE NON-TREATED FOOTCOMPARED WITH THE NON-TREATED FOOT

• Significant reduction in hyperkeratosis on the foot treated. (-1.2 )Significant reduction in hyperkeratosis on the foot treated. (-1.2 )

• No significant variation of hyperkeratosis on the non-treated foot.(- 0.2) No significant variation of hyperkeratosis on the non-treated foot.(- 0.2)

Score clinique *

AFTER TWO WEEKS OF TREATMENTAFTER TWO WEEKS OF TREATMENTBEFORE TREATMENTBEFORE TREATMENT

0

1

2

3

DO FOOTTREATED

DO FOOT NOTTREATED

Clinical score*

0

1

2

3

D14 FOOTTREATED

D14 FOOT NOTTREATED

-1.2

Score* : presence of hyperkeratosis 0 = zero / 1 = slight / 2 = average/ 3 = significant/ 4 = very significant/ 5 Score* : presence of hyperkeratosis 0 = zero / 1 = slight / 2 = average/ 3 = significant/ 4 = very significant/ 5 = severe = severe

3333

STUDY ON THE USE OF AKILDIA CREAM FOR SPORTSTUDY ON THE USE OF AKILDIA CREAM FOR SPORT


EXPERIMENT IN THE SPORTING ENVIRONMENTEXPERIMENT IN THE SPORTING ENVIRONMENT

ASSESSMENT AND RESEARCH DEPARTMENT OF CREPS ASSESSMENT AND RESEARCH DEPARTMENT OF CREPS

DR GENSON DR GENSON

STUDY CONDITIONS:STUDY CONDITIONS:

• 10 walkers with diabetes10 walkers with diabetes

- Fragile skin problems (ulcers…) - Fragile skin problems (ulcers…) - 80 % suffering from pain- 80 % suffering from pain - 100 % with œdemas on the feet- 100 % with œdemas on the feet

•3 month treatment3 month treatment

• 1 application per day1 application per day

• Sporting activity kept upSporting activity kept up

RESULT: ASSESSMENT BY A DOCTOR OF THE OVERALL EFFECTIVENESS OF THE ASSESSMENT BY A DOCTOR OF THE OVERALL EFFECTIVENESS OF THE AKILDIA® CREAM FOR SPORTING ACTIVITIESAKILDIA® CREAM FOR SPORTING ACTIVITIES

Good assessment of the overall effectiveness of the AKILDIA® creamGood assessment of the overall effectiveness of the AKILDIA® creamfor sporting activities.for sporting activities.


% of subjects% of subjects

70%

30%

0%

20%

40%

60%

80%

EXCELLENT EFFECTIVENESS OF AKILDIA FOR 70 % OF SUBJECTS

GOOD EFFECTIVENESS OF AKILDIA CREAM FOR 30% OF SUBJECTS

50% 50%

0 % 0%0%

10%

20%

30%

40%

50%

60%

severe œdema significant œdema

slight œdema no œdema

0% 0%

60 % 40%

0%

10%

20%

30%

40%

50%

60%

severe œdema significant œdema

moderate œdema no oedema

BEFORE TREATMENTBEFORE TREATMENT

RESULT: ASSESSMENT BY A DOCTOR OF THE EFFECTIVENESS OF AKILDIA® CREAM ASSESSMENT BY A DOCTOR OF THE EFFECTIVENESS OF AKILDIA® CREAM

ON THE ON THE REDUCTION OF OEDEMAREDUCTION OF OEDEMA

After 3 months of treatment, clear reduction in œdemas ( 100% slight to zero œdemas against 100 % of After 3 months of treatment, clear reduction in œdemas ( 100% slight to zero œdemas against 100 % of significant to severe œdema before treatment)significant to severe œdema before treatment)


AFTER THREE MONTHS OF TREATMENT WHILE AFTER THREE MONTHS OF TREATMENT WHILE

KEEPING UP SPORTING ACTIVITYKEEPING UP SPORTING ACTIVITY

% de subjects % de subjects

0%40% 40 %

10% 10%0%

20%

40%

60%

80%

No pain Slight pain

Moderate pain Significant pain

Severe pain

BEFORE TREATMENTBEFORE TREATMENT

80%

20% 40 % 0% 0%0%

20%

40%

60%

80%

No pain Slight pain

Moderate pain Significant pain

Severe pain

RESULTRESULT: ASSESSMENT BY A DOCTOR OF THE EFFECTIVENESS : ASSESSMENT BY A DOCTOR OF THE EFFECTIVENESS OF AKILDIA® CREAM ON THE OF AKILDIA® CREAM ON THE REDUCTION OF PAINREDUCTION OF PAIN

Après 3 mois de traitement, nette diminution de la douleur.


% de subjects

AFTER THREE MONTHS OF TREATMENT WHILE AFTER THREE MONTHS OF TREATMENT WHILE

KEEPING UP SPORTING ACTIVITYKEEPING UP SPORTING ACTIVITY

After 3 months of treatment, clear reduction in pain (80 % of the subjects feel no pain, although all After 3 months of treatment, clear reduction in pain (80 % of the subjects feel no pain, although all felt slight to severe pain before).felt slight to severe pain before).

% de subjects

®® AKILDIA AKILDIA TREATMENT AND PREVENTIVE CARE FOR THE FEET TREATMENT AND PREVENTIVE CARE FOR THE FEET OF DIABETICSOF DIABETICSBATH OIL

& TOILET LOTION AKILDIA

SPECIFIC HYGIENE SPECIFIC HYGIENE FOR THE FEET OF FOR THE FEET OF

DIABETICSDIABETICS

®


• ADVANTAGES OF THE PRODUCTADVANTAGES OF THE PRODUCT

- - Practical: can be used without water, no rinsingPractical: can be used without water, no rinsing - Cleans and deodorises the feet- Cleans and deodorises the feet - Avoids maceration - Avoids maceration • ITS ACTIVE SUBSTANCESITS ACTIVE SUBSTANCES

- Essential oils of lemon, lavender - Essential oils of lemon, lavender, thyme and rosemary, thyme and rosemary - Vegetal glycerine- Vegetal glycerine

•RECOMMENDATIONS FOR USE RECOMMENDATIONS FOR USE

Use on a toilet glove, or a cotton cloth, to clean and deodorise the Use on a toilet glove, or a cotton cloth, to clean and deodorise the foot. foot. Do not rinse, and dry immediately Do not rinse, and dry immediately

®®® AKILDIA AKILDIA

TOILETTOILET

LOTIONLOTION

TREATMENT AND PREVENTATIVE TREATMENT AND PREVENTATIVE CARE FOR THE FEET OF DIABETICSCARE FOR THE FEET OF DIABETICS

• ADVANTAGES OF THE PRODUCTADVANTAGES OF THE PRODUCT

- Concentrated bath oil for feet - Concentrated bath oil for feet - Softens the skin (superfatting agent effect) - Softens the skin (superfatting agent effect)

- Gives a feeling of well-being and relaxation - Gives a feeling of well-being and relaxation

- Contains a complex of fungicidal and bacterial active substances - Contains a complex of fungicidal and bacterial active substances that cleanse the skinthat cleanse the skin

ITS ACTIVE SUBSTANCESITS ACTIVE SUBSTANCES

- - Essential oils of lemon, lavender, thyme and rosemaryEssential oils of lemon, lavender, thyme and rosemary

- Hydrosoluble coconut oil- Hydrosoluble coconut oil - Fungistatic agent- Fungistatic agent

• RECOMMENDATIONS FOR USERECOMMENDATIONS FOR USE

Dilute 1 cap in 5 litres of warm water (35 to 37 ° maximum) Dilute 1 cap in 5 litres of warm water (35 to 37 ° maximum) Bathe the feet for 5 minutes (not more)Bathe the feet for 5 minutes (not more) Dry the feet carefully without rubbingDry the feet carefully without rubbing

®®® AKILDIA AKILDIA HYGIENE FOR FEET OF DIABETICSHYGIENE FOR FEET OF DIABETICS

ESSENTIAL OIL BATHESSENTIAL OIL BATH

DIABETESDIABETES


Advice to be given to a diabetic Advice to be given to a diabetic

patient regarding foot carepatient regarding foot care


Monthly pedicure ( removal of hyperkeratoses, cutting of nails, Monthly pedicure ( removal of hyperkeratoses, cutting of nails, ortheses to compensate for statics of the sole of the foot)ortheses to compensate for statics of the sole of the foot)

Inform your chiropodist of your diabetesInform your chiropodist of your diabetes Examine your feet daily Examine your feet daily At the slightest injury or wound, consult your doctor urgentlyAt the slightest injury or wound, consult your doctor urgently Regular and careful foot hygieneRegular and careful foot hygiene

Be careful when taking a bath (temperature, length)Be careful when taking a bath (temperature, length) Dry the feet well ( maceration, mycosis)Dry the feet well ( maceration, mycosis) Do not use corn removersDo not use corn removers File your nails ( do not use scissors)File your nails ( do not use scissors) Wear appropriate shoes ... Wear appropriate shoes ... Do not use a hot water bottle, electric blanket…Do not use a hot water bottle, electric blanket… Never walk bare footNever walk bare foot Use a foot care product daily to ensure the protective role of the skinUse a foot care product daily to ensure the protective role of the skin

Date post:	16-Jan-2016
Category:	Documents
Upload:	grant-floyd
View:	233 times
Download:	0 times

DERMO ADJUVANTS SPECIFIFIC TREATMENT FOR DIABETIC FEET AKILDIA DERMO ADJUVANTS SPECIFIFIC TREATMENT...

Documents